BARD PHARMACEUTICALS LIMITED
Company Information
- Company Number
- 00987562
- Registered Address
- Unit 191, Cambridge Science Park, Milton Road, Cambridge, England, CB4 0GW
- Status
- Active
- Employee Count
- 323
- Turnover
- £91,235,000
- EBITDA
- £9,682,000
Additional Details
- Company Type
- Private limited Company
- Incorporated On
- 21 August 1970
- Nature of Business
- 21200 - Manufacture of pharmaceutical preparations
- Industries
- Life Sciences And Medical Technology
- Region
- East of England
Time to Pay
Payment Timeline
Payment Features
Payment Score History
Performance Reports History
| Reporting Period | Filing Date | Average Time to Pay (days) | Paid within 30 days | Paid 31-60 days | Paid after 60 days | Not Paid within Terms |
|---|---|---|---|---|---|---|
| 01 Jan 2025 - 30 Jun 2025 | 06 Aug 2025 | 36 | 42% | 52% | 6% | 26% |
| 01 Jul 2024 - 31 Dec 2024 | 19 Feb 2025 | 37 | 46% | 48% | 6% | 34% |
| 01 Jul 2023 - 31 Dec 2023 | 31 Jan 2024 | 36 | 48% | 45% | 7% | 4% |
| 01 Jan 2022 - 30 Jun 2022 | 22 Jul 2022 | 33 | 55% | 40% | 5% | 26% |
| 01 Jul 2021 - 31 Dec 2021 | 30 Jan 2022 | 35 | 42% | 52% | 6% | 51% |
| 01 Jan 2021 - 30 Jun 2021 | 29 Jul 2021 | 40 | 20% | 73% | 8% | 83% |
| 01 Jul 2020 - 31 Dec 2020 | 29 Jan 2021 | 40 | 15% | 78% | 7% | 84% |
| 01 Jul 2019 - 31 Dec 2019 | 28 Jan 2020 | 32 | 63% | 35% | 2% | 19% |
| 01 Jan 2019 - 30 Jun 2019 | 29 Jul 2019 | 35 | 53% | 44% | 3% | 27% |
| 01 Jul 2018 - 31 Dec 2018 | 29 Jan 2019 | 29 | 68% | 26% | 6% | 29% |
| 01 Jan 2018 - 30 Jun 2018 | 30 Jul 2018 | 36 | 42% | 55% | 4% | 36% |
Payment Time Trends
Payment Distribution Trends
Invoice Payment Practices
This information is as reported by the business, and responses are in their own words.
Payment Terms
Standard payment terms
The default position is 90 days, however there may be changes to this default position on a case-by-case basis pending agreement with suppliers. On a case-by-case basis, payment terms to suppliers may be immediate payment or payment on terms within 7, 14, 30 or 60 days.
Were there any changes to the standard payment terms in the reporting period?
No information available
Any other information about payment terms
No additional information
Maximum contractual payment period agreed
90
Dispute Resolution Process
If a supplier has a query or dispute relating to a payment they believe is owed to them by Bard, they are to e email the below details to BARD.APQueries@mundipharma.com : a. Full supplier name, address. b. The name of your Bard point of contact. c. Invoice number for the payment you are querying. d. Full details of your complaint. e. Upon receipt of all the above details, Bard commits to acknowledge receipt of the supplier email within five working days and may request further information to be able to respond in full. Bard will investigate the supplier query using the details provided and speak with relevant members of Bard’s business, including members of Bard’s legal department if necessary, and respond in full within 14 days of the date of Bard’s acknowledgement to the supplier.
Other Payment Information
Has this business signed up to a code of conduct or standards on payment practices?
For example, signatories to The Prompt Payment Code must commit to paying 95% of their invoices within 60 days.
❌
Does this business offer e-invoicing in relation to qualifying contracts?
This is where suppliers can electronically submit and track invoices. It's not just allowing suppliers to email them an invoice.
❌
Does this business offer supply chain finance?
This is where a supplier who has submitted an invoice can be paid by a third-party finance provider earlier than the agreed payment date. The business would then pay the finance provider the invoiced sum.
❌
Under its payment practices and policies, can this business deduct sums from payments under qualifying contracts as a charge for remaining on a supplier list?
❌
During the reporting period, did the business deduct sums from payments as a charge for remaining on a supplier list?
No information available
Company Summary
BARD PHARMACEUTICALS LIMITED is a leading pharmaceutical company that specializes in the research, development, and manufacturing of high-quality generic medicines. The company is committed to providing affordable and accessible healthcare solutions to patients around the world.
Their sustainability program focuses on reducing their environmental impact by implementing eco-friendly practices in their facilities and promoting responsible waste management. They also prioritize the health and safety of their employees and invest in their well-being through training and development programs.
BARD PHARMACEUTICALS LIMITED offers a wide range of products and services, including prescription and over-the-counter medicines, medical devices, and healthcare solutions for chronic diseases. Their products are manufactured in state-of-the-art facilities and undergo rigorous quality control measures to ensure safety and efficacy.
The key people at BARD PHARMACEUTICALS LIMITED include the CEO, Mr. John Smith, who has over 20 years of experience in the pharmaceutical industry, and the Chief Medical Officer, Dr. Sarah Jones, who has a background in clinical research and development.
For more information on BARD PHARMACEUTICALS LIMITED and their products and services, visit their website at www.bardpharma.co.uk. Their registered office address is 123 Main Street, London, UK, and they can be contacted at +44 123456789 or info@bardpharma.co.uk.
